AdaptHealth Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for AdaptHealth stock ranges from a low of $11 to a high of $16. The average analyst price target of $13.4 forecasts a 48.39% increase in the stock price over the next year.

Price Target: $13.40 (+48.39%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11	$13.4	$13	$16
Change	+21.82%	+48.39%	+43.96%	+77.19%

Analyst Ratings

The average analyst rating for AdaptHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	3	3	3	3	3	3
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Macdonald Truist Securities	Truist Securities	Strong Buy Maintains $14 → $13	Strong Buy	Maintains	$14 → $13	+43.96%	May 12, 2025
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $14 → $13	Buy	Maintains	$14 → $13	+43.96%	May 8, 2025
Eric Coldwell Baird	Baird	Buy Maintains $14 → $16	Buy	Maintains	$14 → $16	+77.19%	Feb 27, 2025
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $13 → $14	Strong Buy	Maintains	$13 → $14	+55.04%	Feb 26, 2025
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $11 → $14	Buy	Maintains	$11 → $14	+55.04%	Feb 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.32B

from 3.26B

1.72%

from 3.26B

Revenue Next Year

3.47B

from 3.32B

4.61%

from 3.32B

EPS This Year

0.89

from 0.61

45.48%

from 0.61

EPS Next Year

1.04

from 0.89

17.47%

from 0.89

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.07B	2.47B	2.97B	3.20B	3.26B	3.32B	3.47B	3.69B
Revenue Growth	102.15%	130.24%	20.51%	7.73%	1.90%	1.72%	4.61%	6.34%
EPS	-3.08	0.67	0.33	-5.31	0.61	0.89	1.04	1.30
EPS Growth	-	-	-50.00%	-	-	45.48%	17.47%	24.27%
Forward PE	-	-	-	-	-	10.18	8.66	6.97
No. Analysts	-	-	-	-	-	11	11	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	3.4B	3.7B	4.0B
Avg	3.3B	3.5B	3.7B
Low	3.2B	3.3B	3.4B

Revenue Growth

Revenue Growth	2025	2026	2027
High	5.3%	10.4%	14.0%
Avg	1.7%	4.6%	6.3%
Low	-2.6%	-1.3%	-1.4%

EPS Forecast

EPS	2025	2026	2027
High	1.16	1.45	1.63
Avg	0.89	1.04	1.30
Low	0.60	0.80	0.99

EPS Growth

EPS Growth	2025	2026	2027
High	89.3%	63.3%	56.1%
Avg	45.5%	17.5%	24.3%
Low	-2.0%	-9.4%	-5.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.